Viewing Study NCT01294618


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
Study NCT ID: NCT01294618
Status: COMPLETED
Last Update Posted: 2019-05-28
First Post: 2011-02-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module